146 related articles for article (PubMed ID: 32847094)
21. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.
Morelli AE; Larregina AT; Smith-Arica J; Dewey RA; Southgate TD; Ambar B; Fontana A; Castro MG; Lowenstein PR
J Gen Virol; 1999 Mar; 80 ( Pt 3)():571-583. PubMed ID: 10091995
[TBL] [Abstract][Full Text] [Related]
22. Effect of flanking matrix attachment regions on the expression of microinjected transgenes during preimplantation development of mouse embryos.
Gutiérrez-Adán A; Pintado B
Transgenic Res; 2000 Apr; 9(2):81-9. PubMed ID: 10951692
[TBL] [Abstract][Full Text] [Related]
23. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors.
Alexopoulou AN; Couchman JR; Whiteford JR
BMC Cell Biol; 2008 Jan; 9():2. PubMed ID: 18190688
[TBL] [Abstract][Full Text] [Related]
24. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
[TBL] [Abstract][Full Text] [Related]
25. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
26. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional activities of human elongation factor-1α and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer.
Eun K; Hong N; Jeong YW; Park MG; Hwang SU; Jeong YIK; Choi EJ; Olsson PO; Hwang WS; Hyun SH; Kim H
PLoS One; 2020; 15(6):e0233784. PubMed ID: 32492024
[TBL] [Abstract][Full Text] [Related]
28. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
[TBL] [Abstract][Full Text] [Related]
29. Combining fibroblast isolation with lentiviral gene transfer to validate transgene expression in mice following pronucleus injection.
Rössler OG; Lesch A; Thiel G
Transgenic Res; 2016 Dec; 25(6):839-846. PubMed ID: 27506594
[TBL] [Abstract][Full Text] [Related]
30. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
[TBL] [Abstract][Full Text] [Related]
31. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
32. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
[TBL] [Abstract][Full Text] [Related]
33. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
[TBL] [Abstract][Full Text] [Related]
34. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
Panet R; Marcus M; Atlan H
J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
[TBL] [Abstract][Full Text] [Related]
36. Blastocyst Formation Rate and Transgene Expression are Associated with Gene Insertion into Safe and Non-Safe Harbors in the Cattle Genome.
Ghahfarokhi MK; Dormiani K; Mohammadi A; Jafarpour F; Nasr-Esfahani MH
Sci Rep; 2017 Nov; 7(1):15432. PubMed ID: 29133827
[TBL] [Abstract][Full Text] [Related]
37. Use of cloned genetically modified human fibroblasts to assess long-term survival in vivo.
Krueger GG; Jorgensen CM; Petersen MJ; Mansbridge JN; Morgan JR
Hum Gene Ther; 1997 Mar; 8(5):523-32. PubMed ID: 9095404
[TBL] [Abstract][Full Text] [Related]
38. Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
Xiang J; Munegowda MA; Deng Y
Cancer Gene Ther; 2009 May; 16(5):430-8. PubMed ID: 19096444
[TBL] [Abstract][Full Text] [Related]
39. Enhancing and suppressing effects of dexamethasone on transgene expression in vitro.
Akahane M; Kuriyama S; Ohgushi H; Akahane T; Kawamura K; Watanabe S; Funakoshi F; Yoshiji H; Ikenaka K; Takakura Y
Int J Mol Med; 2002 Jul; 10(1):107-12. PubMed ID: 12060860
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.
Tang DC; Jennelle RS; Shi Z; Garver RI; Carbone DP; Loya F; Chang CH; Curiel DT
Hum Gene Ther; 1997 Nov; 8(17):2117-24. PubMed ID: 9414259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
